• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Scientists from Erasmus MC and Utrecht University claim the discovery of an antibody against Covid-19

Gert van der Hoek

In Memoriam - Editor, Senior Moderator
Scientists from Erasmus MC and Utrecht University claim the discovery of an antibody against Covid-19, the disease caused by the new coronavirus: SARS-CoV-2.

The scientific publication of the group of ten scientists is ready for assessment by the leading journal Nature, reports Erasmus Magazine, which calls the discovery a world first.

Prevents infection
"The antibody prevents the virus from being able to infect and can also help in the detection of the virus," says professor of cell biology Frank Grosveld, one of the discoverers on behalf of Erasmus MC.

The article with findings from the scientists was already published on Thursday on a website called BioRxiv, on which biologists can publish their research and to which colleagues can respond.

The summary talks about an antibody to SARS2, the coronavirus that causes the current pandemic with COVID-19.
 
[h=1]A human monoclonal 1 antibody blocking SARS-CoV-2 infection[/h] Chunyan Wang, Wentao Li, Dubravka Drabek, Nisreen M.A. Okba, Rien van Haperen, Albert D.M.E. Osterhaus, Frank J.M. van Kuppeveld, Bart L. Haagmans, Frank Grosveld, Berend-Jan Bosch
doi: https://doi.org/10.1101/2020.03.11.987958

This article is a preprint and has not been certified by peer review [what does this mean?]. [h=2]Abstract[/h]
The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV). This cross-neutralizing antibody targets a communal epitope on these viruses and offers potential for prevention and treatment of COVID-19.
 
Back
Top